Haemonetics Corp (NYSE:HAE)
| 73.64 Delayed Data As of 4:00pm ET |  -0.91 / -1.22%Today’s Change | 43.50 Today|||52-Week Range 79.45 | +38.84% Year-to-Date |
Latest HAE News | Press Releases
No recent news for Haemonetics Corp.
Today’s Trading
| Previous close | 74.55 |
| Today’s open | 73.63 |
| Day’s range | 72.68 - 73.92 |
| Volume | 392,861 |
| Average volume (3 months) | 418,560 |
| Market cap | $3.8B |
Data as of 4:00pm ET, 09/29/2022
Growth & Valuation
| Earnings growth (last year) | -45.80% |
| Earnings growth (this year) | +8.62% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +14.10% |
| P/E ratio | 56.2 |
| Price/Sales | 3.30 |
| Price/Book | 5.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ICUIICU Medical Inc | -1.13 | -0.74% |
| IARTIntegra Lifesciences... | +0.28 | +0.65% |
| AXNXAxonics Inc | -0.22 | -0.31% |
| ---- |
Data as of 4:00pm ET, 09/29/2022
Financials
| Next reporting date | November 8, 2022 |
| EPS forecast (this quarter) | $0.68 |
| Annual revenue (last year) | $993.2M |
| Annual profit (last year) | $43.4M |
| Net profit margin | 4.37% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
